DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / A••••• L••• S••••••• L••
A••••• L••• S••••••• L••
Venture Capital Firm I Home Innovation. Clarity. Execution. A Venture Capital Firm for Visionary Innovators. A••••• L••• S••••••• is one of the leading tr ...
both early and growth/opportunity families, reported GAV $714M
Importance
50
elevated
Active deployment
55
elevated
Emerging
0
low
Completeness
75
high
Freshness
99
high
Research priority
20
moderate
Identity and regulatory footprint
- Headquarters
- London, United Kingdomadviserinfo.sec.gov
- Office address
- 27 FITZROY SQUARE, London, W1T 6ESadviserinfo.sec.gov
- Business phone
- 44-0-20-7932-2100adviserinfo.sec.gov
- Website
- a•••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 27, 2024
- Private funds reported
- 6 (6 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $714Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- contact@adventls.comadventls.compublished by the subject
- business phone
- 44-0-20-7932-2100adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
56 observed deals
Stated (the firm’s website)
- Sectors
- biotech
- Stages
- seed, series a, growth
- Geography
- europe, global, uk, usa
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 96%Other Technology 2%Other Health Care 2%
lead rate n/afollow-on rate n/anew logos, 12 months 56
Funds and vehicles
7 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| A••••• L••• S••••••• G••••• F••• L• | Growth fund | 2024 form d first sale | Fundraising | unknown | unknown | $9.8M | Nov 7, 2025 |
| A••••••••• I••••• F••• L• | Fund | 2020 form d first sale | Mature | $51.8M Mar 27, 2024 | 60 | $41.6M | Nov 6, 2020 |
| A••••• L••• S••••••• I• C•••••••• L• | SPV or co-invest vehicle | 2020 adv first reported | Mature | $17.9M Mar 27, 2024 | 2 | unknown | unknown |
| A••••• L••• S••••••• F••• I•• L• | Fund | 2018 form d first sale | Harvest | $147M Mar 27, 2024 | 10 | $24.8M | Dec 6, 2019 |
| A••••• L••• S••••••• F••• I• L• | Fund | 2014 form d first sale | Harvest | $166M Mar 27, 2024 | 15 | $226M of $226M | Nov 3, 2014 |
| B••••••• L•• | Fund | 2012 form d first sale | Harvest | $37.7M Mar 27, 2024 | 84 | $146M of $200M | Aug 1, 2018 |
| A••••• L••• S••••••• F••• I• L• | Fund | unknown | Unknown | $293M Mar 27, 2024 | 13 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
22 current, 0 departed
M•••• K•••• M•••• K••••
Board or advisoryClinical Advisor
D•••••• S••••••
General partnerGeneral Partner · since Jan 1, 2023
D•••••• S•••••• D•••••• S••••••
General partnerGeneral Partner
K••••• M•••••• K••••• M••••••
General partnerGeneral Partner
M••••••• S•••••• A•••• M••••
General partnerGeneral Partner · since Nov 1, 2010
R•• P••••• R•• P•••••
General partnerGeneral Partner
R••••• P•••••
General partnerGeneral Partner · since Nov 1, 2010
S••••• K••••• M••••••
General partnerGeneral Partner · since Jul 1, 2014
S••••• J••••• S••••• J•••••
General partnerGeneral Partner
S•••••• M•••• S•••••• M••••
General partnerGeneral Partner
G••• J••••• G••• J•••••
Investor relationsInvestor Relations Partner
J••• R•• J••• R••
Operating partnerOperating Partner
J•• M•••• J•• M••••
Operating partnerOperating Partner
F••••• M••••• F••••• M•••••
OtherHead of Scientific Evaluation
S•••• P••••• S•••• P•••••
PartnerG••••• Partner
B••••• T••••• B••••• T•••••
Platform and operationsExecutive Assistant
V••••••• S•••• V••••••• S••••
Platform and operationsFinancial Controller
R••••• P•••• R••••• P••••
PrincipalFinancial Director
A•••• H••••• A•••• H•••••
Venture partnerVenture Partner
D•• D••••••• D•• D•••••••
Venture partnerVenture Partner
K•••••• B••••• K•••••• B•••••
Venture partnerVenture Partner
R•• L••• R•• L•••
Venture partnerVenture Partner
Investments on record
56 edges, 56 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
27 relationships from shared deals, counted for the whole firm
Aperture Management LLC 2 shared · recurringAccel 2 shared · recurringTouring Capital LLC 1 shared · one timeOpenAI 1 shared · one timeSanderling Management Company, LLC 1 shared · one timeQED Investors, LLC 1 shared · one timeOmega Fund Management, LLC 1 shared · one timeLakehouse Ventures, LLC 1 shared · one timeUpper90 1 shared · one timeStartup Capital Ventures Management Co III, LLC 1 shared · one timeVestedworld 1 shared · one timeK1 Investment Management LLC 1 shared · one timeCollaborative Fund Management LLC 1 shared · one timeHaun Ventures Management LP 1 shared · one timeElectric Capital Partners, LLC 1 shared · one timeWarburg Pincus LLC 1 shared · one timeT2 Capital Management, LLC 1 shared · one timeDecheng Capital LLC 1 shared · one timeTEN Eleven Ventures, LLC 1 shared · one timeMission Biocapital 1 shared · one timeHuman Capital 1 shared · one timePappas Ventures 1 shared · one timeNEW Rhein Healthcare Investors LLC 1 shared · one timeA.capital Ventures 1 shared · one timeMitsui & Co. Global Investment, Inc. 1 shared · one timeKhosla Ventures, LLC 1 shared · one timeProspect Management Co. II, LLC 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
9 dated events
- Sep 16, 2026CN no longer listed on A••••• L••• S••••••• L••'s portfolio pageRemoved from portfolio pagePortfolioInferenceC•Venture organization websites (about, team, portfolio, thesis, news pages)
- Jan 1, 2023D•••••• S•••••• joined Schedule A of A••••• L••• S••••••• L•• as General Partner
- Mar 29, 2022B••••••• L•• first reported on Form ADV by A••••• L••• S••••••• L•• (Venture Capital Fund), GAV $61,716,000Fund first reported on Form ADVFundsFactB••••••• L••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 12, 2021A••••••••• I••••• F••• L• first reported on Form ADV by A••••• L••• S••••••• L•• (Venture Capital Fund), GAV $51,693,000Fund first reported on Form ADVFundsFactA••••••••• I••••• F••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 4, 2020A••••• L••• S••••••• I• C•••••••• L• first reported on Form ADV by A••••• L••• S••••••• L•• (Venture Capital Fund), GAV $12,416,300Fund first reported on Form ADVFundsFactA••••• L••• S••••••• I• C•••••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 22, 2019A••••• L••• S••••••• F••• I•• L• first reported on Form ADV by A••••• L••• S••••••• L•• (Venture Capital Fund), GAV $140,270,000Fund first reported on Form ADVFundsFactA••••• L••• S••••••• F••• I•• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 9, 2015A••••• L••• S••••••• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 9, 2015A••••• L••• S••••••• F••• I• L• first reported on Form ADV by A••••• L••• S••••••• L•• (Venture Capital Fund), GAV $210,000,000Fund first reported on Form ADVFundsFactA••••• L••• S••••••• F••• I• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 9, 2015A••••• L••• S••••••• F••• I• L• first reported on Form ADV by A••••• L••• S••••••• L•• (Venture Capital Fund), GAV $173,502,000Fund first reported on Form ADVFundsFactA••••• L••• S••••••• F••• I• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Multi-stage venture firm (confirmed, 95%, cls-1)both early and growth/opportunity families, reported GAV $714M
Evidence
41 observations from 2 sources